SPMS01 Developing RNA Binding Peptide Nucleic Acids Contents 1. - - PowerPoint PPT Presentation

spms01
SMART_READER_LITE
LIVE PREVIEW

SPMS01 Developing RNA Binding Peptide Nucleic Acids Contents 1. - - PowerPoint PPT Presentation

SPMS01 Developing RNA Binding Peptide Nucleic Acids Contents 1. Introduction of the background 2. Hypothesis 3. Methodology 4. Results and Discussion 5. Conclusion 6. Future work and Applications Introduction Alzheimers A chronic


slide-1
SLIDE 1

SPMS01 Developing RNA Binding Peptide Nucleic Acids

slide-2
SLIDE 2

Contents

  • 1. Introduction of the background
  • 2. Hypothesis
  • 3. Methodology
  • 4. Results and Discussion
  • 5. Conclusion
  • 6. Future work and Applications
slide-3
SLIDE 3

Introduction

slide-4
SLIDE 4

➔ A chronic neurodegenerative disease affecting approximately 29.8 million people worldwide. ➔ This disease presents a characteristic early symptom of short term memory loss.

Alzheimer’s

slide-5
SLIDE 5

A quick summary!

Extrapolate to greater potency and less side effects for both Alzheimer’s and other neurodegenerative disease applications. Develop a promising way to tackle Alzheimer’s through the synthesis of PNAs complementary to the tau pre-mRNA. A novel binding mechanism that targets both duplex and single regions in the pre- mRNA Enables reduction of the isoform ratio by exploring the therapeutic applications of the PNA Value-adds to the field of research

slide-6
SLIDE 6

Tau Hypothesis

➔ Hyperphosphorylated tau proteins pair up and form neurofibrillary tangles inside nerve cell bodies. ➔ The cell microtubules disintegrate, destroying the structure of the cell's cytoskeleton which collapses the neuron's transport system.

slide-7
SLIDE 7

Hypothesis

slide-8
SLIDE 8

Binding affinity of the PNA strands with the RNA would be higher when manually synthesized monomers such as L, Q and E are used and when they are both single and double stranded resulting in the formation of both duplex and triplex structures.

Tau Hypothesis

disintegration of microtubules which disrupt neuron cell transport system

slide-9
SLIDE 9

Methodology

slide-10
SLIDE 10
slide-11
SLIDE 11

1

1 Solid Phase Peptide Synthesis

2

Purification of PNAs

3

3 Polyacrylamide Gel Electrophoresis (PAGE)

Methodology

slide-12
SLIDE 12

➔ Synthesis of two PNA strands, with sequences NH2-Lys- TAAAAALTLT-CONH2 and NH2-Lys-GGACLELELT-CONH2 ➔ PNA monomers are supported by solid methyl benzhydrylamine hydrochloride polystyrene (mBHA) based resin with Boc Protecting group ➔ Wash resin with dichloromethane (DCM) and dimethylformamide (DMF) repeatedly with exposure to nitrogen gas ➔ Add coupling solution ➔ Perform Kaiser's test ➔ Neutralisation ➔ Repeat procedure manually for synthesis of the entire strand

1

Solid Phase Peptide Synthesis

slide-13
SLIDE 13

➔ Using RP.HPLC ➔ PNA oligomer was first cleaved from the resin ➔ PNA oligomer that precipitated out was then dissolved in water and purified using double RP.HPLC so that the purest samples are used in PAGE

2

Purification of PNAs

slide-14
SLIDE 14

3

Polyacrylamide Gel Electrophoresis (PAGE)

➔ Gel was placed at 4 degree celsius for 5 hours overnight ➔ The gels were then stained in ethidium bromide for 30 mins ➔ Visualisation using Typhoon Trio Variable Mode Imager. ➔ Testing of the binding affinity of the PNA strands with their complementary double stranded RNA molecule

slide-15
SLIDE 15

Results and discussion

slide-16
SLIDE 16

Results and Discussion

Lower lane Upper lane Second RNA First RNA

slide-17
SLIDE 17

A decrease in the 4-repeat/ 3- repeat (4R/3R) isoforms

2

Exon 10 inclusion during splicing

1

The formation

  • f

neurofibrillary tangles are significantly inhibited.

3

The highly

successful

and

remarkable

binding shown on the gel indicates a similar binding mechanism for the tau pre mRNAs and the PNAs. Prevent gain of function mutation: Hairpin loop is destabilised to form a single strand with greater accessibility to splicing elements such as the U1snRNP.

slide-18
SLIDE 18

Future work and applications

slide-19
SLIDE 19

➔ Pave way for DNA silencing using duplex PNA. ◆ Since the binding affinity is an important factor affecting the targeting and inhibition

  • f the RNA.

➔ There is a great potential with regards to the production of such drugs due to the higher possibility

  • f mass production with less

contamination as compared to antibodies

Applications Future Work

➔ The actual effect and impact of the PNA strands in the cellular setting has to be tested. ◆ Thus, cell culture studies are a must to test the actual effect

  • f the synthesized PNA on the

cells. ➔ The exact ratio between the 4R and 3R isoforms can then be identified to assess the significance

  • f our solution.
slide-20
SLIDE 20

Conclusion

slide-21
SLIDE 21

On the whole, for this project, we have focused on the increasing of the binding affinity of the PNA with the target through the development of a new duplex and triplex binding system and have proven the increase in the binding as well.

  • Alzheimer's disease. (2018, December 08). Retrieved from https://www.mayoclinic.org/diseases-conditions/alzheimers-disease/symptoms-causes/syc-20350447
  • Toh, D. K., Patil, K. M., & Chen, G. (2017). Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified

Peptide Nucleic Acids. Journal of Visualized Experiments, (127). doi:10.3791/56221 Retrieved from: https://www.ncbi.nlm.nih.gov/pubmed/28994801

  • (Gupta & Tomar R., 2012): Antisense Technology In Kumar, Gupta & Mohan (Ed.) Biotechnology in Medicine and Agriculture Principles and Practices ( pp 297-312 )
slide-22
SLIDE 22

Thank you

slide-23
SLIDE 23
slide-24
SLIDE 24
slide-25
SLIDE 25
slide-26
SLIDE 26
slide-27
SLIDE 27
slide-28
SLIDE 28

All images self taken unless otherwise stated